Chelator Fragment Libraries for Targeting Metalloproteinases

No abstract is available for this paper.

• Publication year

  2010

• Venue

  ChemMedChem

• Publication date

  2010-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/cmdc.200900516PMID 20058293PMCID PMC2825879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor.

  2009cited by this paper
• Zinc‐Binding Groups Modulate Selective Inhibition of MMPs

  2008cited by this paper
• Recent developments in fragment-based drug discovery.

  2008cited by this paper
• The Design of Inhibitors for Medicinally Relevant Metalloproteins

  2007cited by this paper
• A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.

  2007cited by this paper
• Structure- and fragment-based approaches to protease inhibition.

  2006cited by this paper
• Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity

  2006cited by this paper
• Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies.

  2006cited by this paper
• A high-throughput screening approach to anthrax lethal factor inhibition.

  2006cited by this paper
• Evaluation and Binding‐Mode Prediction of Thiopyrone‐Based Inhibitors of Anthrax Lethal Factor

  2006cited by this paper
• Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.

  2006cited by this paper
• A new role for old ligands: discerning chelators for zinc metalloproteinases.

  2006cited by this paper
• Fragment-based drug design: how big is too big?

  2006cited by this paper
• Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases.

  2006cited by this paper
• Identification of Novel Anthrax Lethal Factor Inhibitors Generated by Combinatorial Pictet–Spengler Reaction Followed by Screening in situ

  2005cited by this paper
• Efficient synthetic inhibitors of anthrax lethal factor.

  2005cited by this paper
• Identification of small molecule inhibitors of anthrax lethal factor

  2004cited by this paper
• New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.

  2004cited by this paper
• Ligand efficiency: a useful metric for lead selection.

  2004cited by this paper
• Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin.

  2001cited by this paper
• Solid-phase synthesis of an arylsulfone hydroxamate library.

  2000cited by this paper
• Drug-like properties and the causes of poor solubility and poor permeability.

  2000cited by this paper
• Stromelysin Inhibitors Designed from Weakly Bound Fragments: Effects of Linking and Cooperativity

  1997cited by this paper
• Development and Application of a Continuous Microwave Reactor for Organic Synthesis

  1994cited by this paper
• Lipophilic coordination compounds: aluminum, gallium, and indium complexes of 1-aryl-3-hydroxy-2-methyl-4-pyridinones

  1991cited by this paper

• Developments and challenges in hit progression within fragment-based drug discovery.

  2026cites this paper
• Development of Quinoline‐Isoxazole Hybrids With Selective Cytotoxicity and EGFR Kinase Binding: In Vitro and In Silico Approaches

  2025cites this paper
• Prediction of Pharmacokinetics of Valeric Acid: Alternative Tool to Minimize Animal Studies.

  2025cites this paper
• In silico ADMET and DFT analysis of methoxy substituted curcumin derivatives

  2024cites this paper
• Probing the metalloproteome: an 8-mercaptoquinoline motif enriches minichromosome maintenance complex components as significant metalloprotein targets in live cells

  2024cites this paper
• ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery

  2024cites this paper
• MolProphet: A One-Stop, General Purpose, and AI-Based Platform for the Early Stages of Drug Discovery

  2024cites this paper
• Discovery of Novel Metalloenzyme Inhibitors Based on Property Characterization: Strategy and Application for HDAC1 Inhibitors

  2024cites this paper
• On the hunt for metalloenzyme inhibitors: Investigating the presence of metal‐coordinating compounds in screening libraries and chemical spaces

  2024cites this paper
• “DompeKeys”: a set of novel substructure-based descriptors for efficient chemical space mapping, development and structural interpretation of machine learning models, and indexing of large databases

  2024cites this paper
• Multiple Binding Modes of Inhibitors to Human Carbonic Anhydrases: An Update on the Design of Isoform-Specific Modulators of Activity.

  2024cites this paper
• Discovery of a Potent, Selective, and Blood-Brain Barrier Permeable Non-nitrocatechol Inhibitor of Catechol-O-methyltransferase.

  2024cites this paper
• Physicochemical properties, drug likeness, ADMET, DFT studies, and in vitro antioxidant activity of oxindole derivatives

  2023cites this paper
• Anticancer Tungstenocenes with a Diverse Set of (O,O–), (O,S–) and (O,N–) Chelates—A Detailed Biological Study Using an Improved Evaluation via 3D Spheroid Models

  2023influential citation
• Computational pharmacology and computational chemistry of 4-hydroxyisoleucine: Physicochemical, pharmacokinetic, and DFT-based approaches

  2023cites this paper
• E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology

  2023cites this paper
• Boronic-Acid-Accelerated Electrophilic Activation of Unprotected Maltols to N-Substituted Hydroxypyridinones in Water.

  2022cites this paper
• Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.

  2022cites this paper
• Fragment screening at AstraZeneca: developing the next generation biophysics fragment set.

  2022cites this paper
• In Silico Identification of Novel Inhibitors Targeting the Homodimeric Interface of Superoxide Dismutase from the Dental Pathogen Streptococcus mutans

  2022cites this paper
• Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis

  2022cites this paper
• Identification of novel xanthine oxidase inhibitors via virtual screening with enhanced characterization of molybdopterin binding groups.

  2022cites this paper
• Hydroxypyridinethione Inhibitors of Human Insulin‐Degrading Enzyme

  2021cites this paper
• Selection of a pH- and temperature-stable laccase from Ganoderma australe and its application for bioremediation of textile dyes.

  2021cites this paper
• Zinc thiotropolone combinations as inhibitors of the SARS-CoV-2 main protease.

  2021cites this paper
• Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands

  2021cites this paper
• SARS-CoV-2 Mpro inhibition by a zinc ion: structural features and hints for drug design.

  2021cites this paper
• ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties

  2021cites this paper
• High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium Complexes

  2021influential citation
• Scopy: an integrated negative design python library for desirable HTS/VS database design

  2020cites this paper
• Synthesis, Modification, and Biological Evaluation of a Library of Novel Water‐Soluble Thiopyridone‐Based Organometallic Complexes and Their Unexpected (Biological) Behavior

  2020cites this paper
• Identification of 3-hydroxy-1,2-dimethylpyridine-4(1H)-thione as a metal-binding motif for the inhibition of botulinum neurotoxin A.

  2020cites this paper
• Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective.

  2020cites this paper
• First insights into the novel class of organometallic compounds bearing a bidentate selenopyridone coordination motif: Synthesis, characterization, stability and biological investigations

  2020cites this paper
• Therapeutic Targeting of MMP-12 for the Treatment of Chronic Obstructive Pulmonary Disease.

  2020cites this paper
• Hydrazides are potent transition-state analogs for glutaminyl cyclase implicated in the pathogenesis of Alzheimer's Disease.

  2020cites this paper
• Developing Ligands to Target Transition Metals in Cancer

  2019cites this paper
• Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition.

  2019cites this paper
• Discovery of N-aryl-pyridine-4-ones as Novel Potential Agrochemical Fungicides and Bactericides.

  2019cites this paper
• Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease.

  2018cites this paper
• Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition

  2018cites this paper
• Targeting Metalloenzymes for Therapeutic Intervention.

  2018cites this paper
• Support Information for : eMolTox : prediction of molecular toxicity with confidence

  2018cites this paper
• Virtual Fragment Screening Identification of a Quinoline‐5,8‐dicarboxylic Acid Derivative as a Selective JMJD3 Inhibitor

  2018cites this paper
• HTS by NMR for the Identification of Potent and Selective Inhibitors of Metalloenzymes.

  2018cites this paper
• Development and Characterization of Quantitative, High-Throughput-Compatible Assays for Proteolytic Degradation of Glucagon

  2018cites this paper
• Water-resistant porous coordination polymers for gas separation

  2017cites this paper
• A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes.

  2017cites this paper
• Identification of a New Zinc Binding Chemotype by Fragment Screening.

  2017cites this paper
• Insight into the remarkable affinity and selectivity of the aminobenzosuberone scaffold for the M1 aminopeptidases family based on structure analysis

  2017cites this paper
• Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.

  2017cites this paper
• Hyaluronic acid based hydroxamate and conjugates with biologically active amines: In vitro effect on matrix metalloproteinase-2.

  2016cites this paper
• Investigating orphan cytochrome P450s in Mycobacterium tuberculosis : insights into enzyme structure, function and inhibitor design

  2016cites this paper
• Inhibitors of the Metalloproteinase Anthrax Lethal Factor.

  2016cites this paper
• Synthetic quinolone signal analogues inhibiting the virulence factor elastase of Pseudomonas aeruginosa.

  2016cites this paper
• Ligand‐induced expansion of the S1′ site in the anthrax toxin lethal factor

  2015cites this paper
• Exploring the Influence of Metalloenzyme Active Sites on Metal-Binding Pharmacophores

  2014cites this paper
• Biophysical Characterization of the vOTU Proteases from the CCHF and Dugbe Nairoviruses

  2014cites this paper
• A noncompetitive inhibitor for Mycobacterium tuberculosis's class IIa fructose 1,6-bisphosphate aldolase.

  2014cites this paper
• Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones.

  2014cites this paper
• ‘Unconventional’ Coordination Chemistry by Metal Chelating Fragments in a Metalloprotein Active Site

  2014cites this paper
• Identification of Small-Molecule Frequent Hitters from AlphaScreen High-Throughput Screens

  2014cites this paper
• Antagonism of a zinc metalloprotease using a unique metal-chelating scaffold: tropolones as inhibitors of P. aeruginosa elastase.

  2013cites this paper
• Development of a high-throughput screen and its use in the discovery of Streptococcus pneumoniae immunoglobulin A1 protease inhibitors.

  2013cites this paper
• Computational exploration of zinc binding groups for HDAC inhibition.

  2013cites this paper
• Probing the S1′ Site for the Identification of Non‐Zinc‐Binding MMP‐2 Inhibitors

  2013cites this paper
• Zinc in Biology

  2013cites this paper
• Fragment library design considerations

  2012cites this paper
• Development of a Comprehensive, Validated Pharmacophore Hypothesis for Anthrax Toxin Lethal Factor (LF) Inhibitors Using Genetic Algorithms, Pareto Scoring, and Structural Biology

  2012cites this paper
• 3-Hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones: Inhibition of the Pseudomonas aeruginosa Virulence Factor LasB.

  2012cites this paper
• Fragment library design

  2012cites this paper
• Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

  2011cites this paper
• From Zn to Mn: The Study of Novel Manganese-binding Groups in the Search for New Drugs against Tuberculosis

  2011cites this paper
• Identification of Novel Matrix Metalloproteinase Inhibitors by Screening of Phenol Fragments Library

  2011cites this paper
• Pyrone derivatives and metals: From natural products to metal-based drugs

  2011cites this paper
• Targeting Metalloproteins by Fragment‐Based Lead Discovery

  2011cites this paper
• Emerging trends in metalloprotein inhibition.

  2011cites this paper
• Diamidodipyrrins as BODIPY dyes and chelator fragment libraries to identify new scaffolds for metalloprotein inhibitors

  2010cites this paper
• Biochemical Characterization of the Cellular Glycosylphosphatidylinositol-linked Membrane Type-6 Matrix Metalloproteinase*

  2010cites this paper